CA2126757A1 - Utilisation de composes trioxolane et diperoxyde en medecine - Google Patents

Utilisation de composes trioxolane et diperoxyde en medecine

Info

Publication number
CA2126757A1
CA2126757A1 CA002126757A CA2126757A CA2126757A1 CA 2126757 A1 CA2126757 A1 CA 2126757A1 CA 002126757 A CA002126757 A CA 002126757A CA 2126757 A CA2126757 A CA 2126757A CA 2126757 A1 CA2126757 A1 CA 2126757A1
Authority
CA
Canada
Prior art keywords
mammal
trioxolane
diperoxide
unsaturated hydrocarbon
terpene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002126757A
Other languages
English (en)
Inventor
Stephen Herman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cliveden Ltde
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/840,388 external-priority patent/US5270344A/en
Application filed by Individual filed Critical Individual
Publication of CA2126757A1 publication Critical patent/CA2126757A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
CA002126757A 1991-12-24 1992-12-17 Utilisation de composes trioxolane et diperoxyde en medecine Abandoned CA2126757A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81396291A 1991-12-24 1991-12-24
US813,962 1991-12-24
US07/840,388 US5270344A (en) 1988-06-24 1992-02-24 Method of treating a systemic disorder using trioxolane and diperoxide compounds
US840,388 1992-02-24

Publications (1)

Publication Number Publication Date
CA2126757A1 true CA2126757A1 (fr) 1993-07-08

Family

ID=27123798

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002126757A Abandoned CA2126757A1 (fr) 1991-12-24 1992-12-17 Utilisation de composes trioxolane et diperoxyde en medecine

Country Status (6)

Country Link
EP (1) EP0644716A4 (fr)
JP (1) JPH08502018A (fr)
AU (1) AU3328293A (fr)
CA (1) CA2126757A1 (fr)
MX (1) MX9207493A (fr)
WO (1) WO1993012654A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
JP3056730B1 (ja) * 1999-03-31 2000-06-26 株式会社バイオ技研 二形性真菌であるカンジダ属に対する形態転換制御活性機能剤
WO2005110388A1 (fr) * 2004-05-10 2005-11-24 Hofmann Robert F Utilisation d'une formulation therapeutique oxydative ciblee dans le traitement du cancer
US20060035881A1 (en) * 2004-06-23 2006-02-16 Hofmann Robert F Use of targeted oxidative therapeutic formulation in endodontic treatment
JPWO2008001553A1 (ja) * 2006-06-28 2009-11-26 株式会社Ｅｒｃテクノロジー オゾン化界面活性剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1210949A (en) * 1914-07-30 1917-01-02 Gen Res Lab Medicinal compound.
US2083572A (en) * 1928-04-25 1937-06-15 Susan M Mckee Process of treating oil
US2356062A (en) * 1942-02-03 1944-08-15 Latimer Lab Inc Therapeutic composition
US4451480A (en) * 1982-04-16 1984-05-29 James Howard Brown Method of treating acne using ozonized materials
US4591602A (en) * 1982-04-16 1986-05-27 James H. Brown Ozonide esters and topical compositions containing same
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5086076A (en) * 1988-06-24 1992-02-04 Stephen Herman Antiviral pharmaceutical compositions comprising a terpene ozonide

Also Published As

Publication number Publication date
EP0644716A4 (en) 1995-04-19
AU3328293A (en) 1993-07-28
MX9207493A (es) 1994-03-31
JPH08502018A (ja) 1996-03-05
WO1993012654A1 (fr) 1993-07-08
EP0644716A1 (fr) 1995-03-29

Similar Documents

Publication Publication Date Title
US5270344A (en) Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5364879A (en) Medical uses of trioxolane and diperoxide compounds
US5190979A (en) Ozonides of terpenes and their medical uses
US9737498B2 (en) Method for treating an inflammation or lesion caused by a virus
AU627908B2 (en) Method for treating viral infection
US5126376A (en) Method for treating viral infection using topical administration
JPH02124817A (ja) 局所投与用炎症性疾患治療剤
US5260342A (en) Method for treating viral infection parenterally
US5190977A (en) Antiviral compositions
CA1338083C (fr) Ozonides de terpenes et leur utilisation medicale
US4626530A (en) Treatment of eye inflammation with biphenamine
US5086076A (en) Antiviral pharmaceutical compositions comprising a terpene ozonide
EA005917B1 (ru) Вирулицидные композиции
US5071879A (en) Systemic antiviral treatment
CA2126757A1 (fr) Utilisation de composes trioxolane et diperoxyde en medecine
IE913787A1 (en) Use of lithium in the treatment or prophylaxis of mollescum contagiosum
JP3064009B2 (ja) 抗ウイルス治療におけるｃ―２７ないしｃ―３２脂肪族アルコールの使用
EP1663195B1 (fr) Procede pour inhiber la croissance de bacteries et de champignons pathogenes et composition microbicide
US20030072828A1 (en) Natural therapeutic composition for the treatment of wounds and sores
US8492443B2 (en) Treatment for herpes simplex virus and other infectious diseases
US4147785A (en) Method for the treatment of onchocerciasis
JP2023120462A (ja) 医薬組成物
EA002267B1 (ru) Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат
Carruthers Dermatological Treatment
CA2591352A1 (fr) Traitement du virus de l'herpes simplex et d'autres maladies infectieuses

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead